Low distribution of synaptic vesicle protein 2A and synaptotagimin-1 in the cerebral cortex and hippocampus of spontaneously epileptic rats exhibiting both tonic convulsion and absence seizure

Neuroscience

Volumn 221, Issue , 2012, Pages 12-20

  Hanaya, R ^a   Hosoyama, H ^a   Sugata, S ^a   Tokudome, M ^a   Hirano, H ^a   Tokimura, H ^a   Kurisu, K ^b   Serikawa, T ^c   Sasa, M ^d   Arita, K ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d Nagisa Clinic   (Japan)

Author keywords

BDNF; Cerebral cortex; Epileptogenesis; GABAergic dysfunction; Synaptic vesicle protein 2A (SV2A); Synaptotagimin 1

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CARRIER PROTEIN; SYNAPSE VESICLE PROTEIN 2A; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ABSENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN ELECTROPHYSIOLOGY; CELL DENSITY; CONTROLLED STUDY; DENTATE GYRUS; ELECTROENCEPHALOGRAPHY; ENTORHINAL CORTEX; FEMALE; FOCAL EPILEPSY; FRONTAL CORTEX; GENERALIZED EPILEPSY; HIPPOCAMPAL SCLEROSIS; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INNER MOLECULAR LAYER; MALE; NERVE CELL; NEUROANATOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRIFORM CORTEX; RAT; RAT STRAIN; SLOW BRAIN WAVE; SPONTANEOUSLY EPILEPTIC RAT; SYMPTOM; TONIC SEIZURE; WISTAR RAT;

AMIDOHYDROLASES; ANIMALS; BRAIN MAPPING; BRAIN WAVES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; FEMALE; FLUORODEOXYGLUCOSE F18; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MUTATION; NERVE TISSUE PROTEINS; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, MUTANT STRAINS; RATS, WISTAR; SEIZURES; SYNAPTOTAGMIN I;

EID: 84864366265     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.06.058     Document Type: Article

References (47)

1. Arzimanoglou A., French J., Blume W.T., Cross J.H., Ernst J.P., Feucht M., Genton P., Guerrini R., Kluger G., Pellock J.M., Perucca E., Wheless J.W. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 2009, 8:82-93.
2. Bajjalieh S.M., Frantz G.D., Weimann J.M., McConnell S.K., Scheller R.H. Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci 1994, 14:5223-5235.
3. 18F]FDG-PET: a case report. Seizure 2010, 19:198-201.
4. 2+-induced exocytosis. J Neurosci 2009, 29:883-897.
5. Crowder K.M., Gunther J.M., Jones T.A., Hale B.D., Zhang H.Z., Peterson M.R., Scheller R.H., Chavkin C., Bajjalieh S.M. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci USA 1999, 96:15268-15273.
6. D'Antuono M., Inaba Y., Biagini G., D'Arcangelo G., Tancredi V., Avoli M. Synaptic hyperexcitability of deep layer neocortical cells in a genetic model of absence seizures. Genes Brain Behav 2006, 5:73-84.
7. de Groot M., Aronica E., Heimans J.J., Reijneveld J.C. Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma. Neurology 2011, 77:532-539.
8. Feng G., Xiao F., Lu Y., Huang Z., Yuan J., Xiao Z., Xi Z., Wang X. Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy. J Mol Neurosci 2009, 39:354-359.
9. Foster J.A., Puchowicz M.J., McIntyre D.C., Herkenham M. Activin mRNA induced during amygdala kindling shows a spatiotemporal progression that tracks the spread of seizures. J Comp Neurol 2004, 476:91-102.
10. Fukao K., Momiyama T., Ishihara K., Ujihara H., Fujita Y., Taniyama K., Serikawa T., Sasa M. Inhibition by gamma-aminobutyric acid system activation of epileptic seizures in spontaneously epileptic rats. Jpn J Pharmacol 1998, 76:387-396.
11. Goffin K., Dedeurwaerdere S., Van Laere K., Van Paesschen W. Neuronuclear assessment of patients with epilepsy. Semin Nucl Med 2008, 38:227-239.
12. Gören M.Z., Onat F., Ozkara C., Ozyurt E., Eşkazan E., Aker R. GABA and l-glutamic acid release in en bloc resection slices of human hippocampus: an in vitro microdialysis study. Neurol Sci 2001, 22:297-302.
13. Hanaya R., Sasa M., Ujihara H., Ishihara K., Serikawa T., Iida K., Akimitsu T., Arita K., Kurisu K. Suppression by topiramate of epileptiform burst discharges in hippocampal CA3 neurons of spontaneously epileptic rat in vitro. Brain Res 1998, 789:274-282.
14. Hanaya R., Sasa M., Sugata S., Tokudome M., Serikawa T., Kurisu K., Arita K. Hippocampal cell loss and propagation of abnormal discharges accompanied with the expression of tonic convulsion in the spontaneously epileptic rat. Brain Res 2010, 1328:171-180.
15. Herholz K., Heiss W.D. Positron emission tomography in clinical neurology. Mol Imag Biol 2004, 6:239-269.
16. Inui T., Yamamura T., Yuasa H., Kawai Y., Okaniwa A., Serikawa T., Yamada J. The spontaneously epileptic rat (SER), a zitter tremor double mutant rat: histopathological findings in the central nervous system. Brain Res 1990, 517:123-133.
17. Ishihara K., Sasa M., Momiyama T., Ujihara H., Nakamura J., Serikawa T., Yamada J., Takaori S. Abnormal excitability of hippocampal CA3 pyramidal neurons of spontaneously epileptic rats (SER), a double mutant. Exp Neurol 1993, 119:287-290.
18. 2+ regulators in neurotransmitter release. Neuron 1999, 24:1003-1016.
19. Ji-qun C., Ishihara K., Nagayama T., Serikawa T., Sasa M. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs. Epilepsia 2005, 46:1362-1370.
20. Kobayashi M., Wen X., Buckmaster P.S. Reduced inhibition and increased output of layer II neurons in the medial entorhinal cortex in a model of temporal lobe epilepsy. J Neurosci 2003, 23:8471-8479.
21. Li S., Reinprecht I., Fahnestock M., Racine R.J. Activity-dependent changes in synaptophysin immunoreactivity in hippocampus, piriform cortex, and entorhinal cortex of the rat. Neuroscience 2002, 115:1221-1229.
22. Löscher W., Ebert U. The role of the piriform cortex in kindling. Prog Neurobiol 1996, 50:427-481.
23. Lynch B.A., Lambeng N., Nocka K., Kensel-Hammes P., Bajjalieh S.M., Matagne A., Fuks B. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004, 101:8966-9861.
24. Matveeva E.A., Vanaman T.C., Whiteheart S.W., Slevin J.T. Asymmetric accumulation of hippocampal 7S SNARE complexes occurs regardless of kindling paradigm. Epilepsy Res 2007, 73:266-274.
25. Ohno Y., Ishihara S., Terada R., Kikuta M., Sofue N., Kawai Y., Serikawa T., Sasa M. Preferential increase in the hippocampal synaptic vesicle protein 2A (SV2A) by pentylenetetrazole kindling. Biochem Biophys Res Commun 2009, 390:415-420.
26. Palacios J.M., Kuhar M.J., Rapoport S.I., London E.D. Increases and decreases in local cerebral glucose utilization in response to GABA agonists. Eur J Pharmacol 1981, 71:333-336.
27. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1996, Academic Press, San Diego. 3rd ed.
28. Rhem S., Mehraein P., Anzil A.P., Deerberg F. A new rat mutant with detective over hairs and spongy degeneration of the central nervous system: clinical pathological studies. Lab Animal Sci 1982, 32:70-73.
29. Rizo J., Rosenmund C. Synaptic vesicle fusion. Nat Struct Mol Biol 2008, 15:665-674.
30. Rothman J.E. Intracellular membrane fusion. Adv Second Messenger Phosphoprotein Res 1994, 29:81-96.
31. Saji H., Iida Y., Takahashi M., Sasa M., Serikawa T., Yamada J., Yokoyama A. Local cerebral glucose utilization in the interictal state of the spontaneously epileptic rat (SER). Brain Res 1993, 601:76-79.
32. Sasa M., Ohno Y., Ujihara H., Fujita Y., Yoshimura M., Takaori S., Serikawa T., Yamada J. Effects of antiepileptic drugs on absence-like and tonic seizures in the spontaneously epileptic rat, a double mutant rat. Epilepsia 1988, 29:505-513.
33. Schivell A.E., Mochida S., Kensel-Hammes P., Custer K.L., Bajjalieh S.M. SV2A and SV2C contain a unique synaptotagmin-binding site. Mol Cell Neurosci 2005, 9:56-64.
34. Serikawa T., Yamada J. Epileptic seizures in rats homozygous for two mutations, zitter and tremor. J Hered 1986, 77:441-444.
35. Shah M.M., Anderson A.E., Leung V., Lin X., Johnston D. Seizure-induced plasticity of h channels in entorhinal cortical layer III pyramidal neurons. Neuron 2004, 44:495-508.
36. Szaflarski J.P., DiFrancesco M., Hirschauer T., Banks C., Privitera M.D., Gotman J., Holland S.K. Cortical and subcortical contributions to absence seizure onset examined with EEG/fMRI. Epilepsy Behav 2010, 18:404-413.
37. Sugata S., Hanaya R., Kumafuji K., Tokudome M., Serikawa T., Kurisu K., Arita K., Sasa M. Neuroprotective effect of levetiracetam on hippocampal sclerosis-like change in spontaneously epileptic rats. Brain Res Bull 2011, 86:36-41.
38. Toering S.T., Boer K., de Groot M., Troost D., Heimans J.J., Spliet W.G., van Rijen P.C., Jansen F.E., Gorter J.A., Reijneveld J.C., Aronica E. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. Epilepsia 2009, 50:1409-1418.
39. van Vliet E.A., Aronica E., Redeker S., Boer K., Gorter J.A. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia 2009, 50:422-433.
40. Westmijse I., Ossenblok P., Gunning B., van Luijtelaar G. Onset and propagation of spike and slow wave discharges in human absence epilepsy: a MEG study. Epilepsia 2009, 50:2538-2548.
41. Xu T., Bajjalieh S.M. SV2 modulates the size of the readily releasable pool of secretory vesicles. Nat Cell Biol 2001, 3:691-698.
42. Yamada J., Serikawa T., Ishiko J., Inui T., Takada H., Kawai Y., Okaniwa A. Rats with congenital tremor and curled whisker and hair. Exp Anim 1985, 34:183-188.
43. Yan H.D., Ji-qun C., Ishihara K., Nagayama T., Serikawa T., Sasa M. Separation of antiepileptogenic and antiseizure effects of levetiracetam in the spontaneously epileptic rat (SER). Epilepsia 2005, 46:1170-1177.
44. Yan H.D., Ishihara K., Hanaya R., Kurisu K., Serikawa T., Sasa M. Voltage-dependent calcium channel abnormalities in hippocampal CA3 neurons of spontaneously epileptic rats. Epilepsia 2007, 48:758-764.
45. Yang J.W., Czech T., Felizardo M., Baumgartner C., Lubec G. Aberrant expression of cytoskeleton proteins in hippocampus from patients with mesial temporal lobe epilepsy. Amino Acids 2006, 30:477-493.
46. Zeng K., Wang X., Wan Y., Yan Y. Enhanced synaptic vesicle traffic in hippocampus of phenytoin-resistant kindled rats. Neurochem Res 2009, 34:899-904.
47. Zhai Q., Gui J., Zhang Y., Qiao H. Children treated for epileptic encephalopathies show improved glucose metabolism. Pediatr Int 2010, 52:883-887.